FDA 483 - VIRGIN SCENT INC - March 11, 2022

An FDA inspection of VIRGIN SCENT INC, an OTC drug repacker and distributor in Gardena, CA, revealed significant deficiencies in their quality system, distribution controls, and production records. The firm lacked a quality control unit, failed to maintain distribution records for hand sanitizer products, and did not prepare batch production records for repacked drugs. These findings indicate a severe lack of adherence to current Good Manufacturing Practices.